ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

US News

When Coke Has a Monster Day, It's the Real Thing

Aug 15 2014 @ 15:27
Okay. I admit it. Sometimes journalists are overcome by hyperbole. But when we say that it was a monster of a day for Monster Beverage Corp. (NASDAQ:MNST) and Coca Cola (NYSE:KO), it is the real thing. When the two companies announced that the rumors about Coke purchasing a position in Monster were true, Monster’s share […]
 

Alibaba Looking for Thieves

Aug 15 2014 @ 12:47
We are only a month away from the highly anticipated IPO of China’s e-commerce giant, Alibaba, when the company says, “Open Sesame,” to anxious investors. Today, however, a cloud is forming over the company’s debut on the New York Stock Exchange as Alibaba is hunting for thieves. There may not be 40 of them, but […]
 

Northcote talks Oklahoma Zink Ranch progress

Aug 14 2014 @ 17:12
Operations Update Northcote (LSE:NCT) has said that it has successfully completed infrastructure improvements at the Zink Ranch Project in Oklahoma and accordingly, the recently recompleted well #13 is now online. The company undertook recompletions at four wells in May 2014, and two of these, wells 8-A and #13, are now in production. The two further […]
 

Wal-Mart Posts Seventh Straight Decline

Aug 14 2014 @ 16:45
Retail megalith Walmart (NYSE:WMT) published its first half results today, reporting its seventh straight quarterly decline in same store sales year-on-year. Walmart share price, nonetheless, rose by 0.49% to 74.39, the neighborhood in which it has been parked since July 2012. Look at the Situation If you haven’t discovered by reading my previous columns about […]
 

Carillion and Balfour Shares Rise But Merger May Be Off

Aug 14 2014 @ 11:51
The Carillion share price (LSE:CLLN) rose 8.0% today, a change of 25.60 pence to 345.60 as investors seem to be responding to the company’s published rationale of why the proposed merger with Balfour Beatty (LSE:BBY) makes good sense. However, the Balfour Beatty share price also gained 4.40 pence, or 1.86%, to 240.90 as the company […]
 

Rex Energy cuts deal with Shell affiliate

Aug 12 2014 @ 16:05
Worth $120m Rex Energy Corporation (Nasdaq:REXX) today announced the acquisition of approximately 208,000 gross (207,000 net) acres in the company’s Butler Operated Area. Acquisition: Rex Energy has entered into a definitive purchase agreement with SWEPI, LP, an affiliate of Royal Dutch Shell, plc to acquire a 100% interest in approximately 208,000 gross (207,000 net) acres […]
 

GSK Again?

Aug 12 2014 @ 12:37
I have struggled for the better part of two days now to not write about GlaxoSmithKline pharmaceuticals (LSE:GSK). I’ve already written about GSK and its share price five times in the first six months of 2014. What more could there possibly be to report? Nonetheless, GSK just seems to have a way of gaining attention, […]
 

Black Diamond nabs former Sony and Gap Executive

Aug 11 2014 @ 16:13
Zeena Freeman to join as President Black Diamond, Inc. (Nasdaq:BDE), a global performance equipment and apparel company, has appointed Zeena Freeman as president. As president, Freeman will succeed Black Diamond Co-Founder Peter Metcalf who will continue to serve as CEO and director. She will be taking over operating responsibility of the Black Diamond Equipment, POC […]
 

UniQure buys InoCard

Aug 11 2014 @ 16:10
Plans to tackle congestive heart failure uniQure (Nasdaq:QURE), a leader in human gene therapy, has announced the acquisition of InoCard GmbH, an innovative, early-stage biotechnology company focused on the development of gene therapy approaches for cardiac disease. InoCard has developed a novel gene therapy to preclinical proof of concept, for the one-time treatment of congestive […]
 

Arrhythmia Research Technology reports 28.1% revenue growth

Aug 07 2014 @ 15:52
– Net sales increased 28.1% over second quarter 2013 to $6.3 million; Net sales were up 16.7% year to date – Gross margin in the second quarter of 2014 expanded 6.7 points to 18.1% Arrhythmia Research Technology, Inc. (NYSE:HRT), operating through its wholly-owned subsidiary, Micron Products, Inc., is a diversified manufacturer of proprietary, highly-engineered technologies...
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com